Keywords: نیتروژن حاوی بیسفسفونات ها; Antiangiogenic therapy; Vascular endothelial growth factor inhibitors; Tyrosine kinase inhibitors; Mammalian target of rapamycin inhibitors; Nitrogen-containing bisphosphonates; Receptor activator of nuclear factor-κB ligand inhibitors; Denosumab;